Rely+On Virkon broad spectrum disinfectant, produced by specialty chemicals company Lanxess, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.
This is the finding of a recent study Lanxess commissioned through the independent analysis laboratory Microbac Laboratories, Inc. in accordance with the U.S. Environmental Protection Agency (EPA) compliant test methods, for products intended for virucidal hard surface disinfection.
Rely+On Virkon achieved rapid and complete inactivation of the SARS-CoV-2 virus at a dilution ratio of 1:100 in just 60 seconds, and at an economical 1:600 in-use dilution with a 10 minute contact time.
Corresponding efficacy data has to be provided for disinfectants that claim to combat SARS-CoV-2. Microbac is one of the few testing laboratories worldwide that U.S. health health authority CDC (Center for Disease Control) has certified to undertake such tests.
Good hygienic cleaning and disinfection practices more important than ever
“Neither a vaccine nor generally approved medications are currently available to us in the fight against the global coronavirus pandemic. So alongside social distancing and hand-washing, disinfection remains a highly important means to help prevent the spread of this life-threatening respiratory illness,” says Anneliese Bischof, Business Director Disinfection at Lanxess. “Right now, good hygiene cleaning and disinfection practices are more important than ever. The fact that Rely+On Virkon inactivates SARS-CoV-2 so quickly will help reassure people that the disinfectant product they are using is both fast and effective in practical use,” underlines Bischof.
Rely+On Virkon is a powder disinfectant concentrate diluted in water for application as a spray on hard surfaces and equipment (non-medical). It can therefore help to reduce the risk of cross-contamination from surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.